Towards patient-based cancer therapeutics.
Broad Institute of Harvard and MIT, Cambridge, Massachusetts, USA. stuart_schreiber@harvard.edu
Schreiber
Stuart L
SL
Shamji
Alykhan F
AF
Clemons
Paul A
PA
Hon
Cindy
C
Koehler
Angela N
AN
Munoz
Benito
B
Palmer
Michelle
M
Stern
Andrew M
AM
Wagner
Bridget K
BK
Powers
Scott
S
Lowe
Scott W
SW
Guo
Xuecui
X
Krasnitz
Alex
A
Sawey
Eric T
ET
Sordella
Raffaella
R
Stein
Lincoln
L
Trotman
Lloyd C
LC
Califano
Andrea
A
Dalla-Favera
Riccardo
R
Ferrando
Adolfo
A
Iavarone
Antonio
A
Pasqualucci
Laura
L
Silva
José
J
Stockwell
Brent R
BR
Hahn
William C
WC
Chin
Lynda
L
DePinho
Ronald A
RA
Boehm
Jesse S
JS
Gopal
Shuba
S
Huang
Alan
A
Root
David E
DE
Weir
Barbara A
BA
Gerhard
Daniela S
DS
Zenklusen
Jean Claude
JC
Roth
Michael G
MG
White
Michael A
MA
Minna
John D
JD
MacMillan
John B
JB
Posner
Bruce A
BA
D000818:Animals; D000970:Antineoplastic Agents / Q000627:therapeutic use*; D004195:Disease Models, Animal; D055808:Drug Discovery; D053263:Gene Regulatory Networks / Q000235:genetics; D006801:Humans; D051379:Mice; D054547:National Cancer Institute (U.S.); D009363:Neoplasm Proteins / Q000378:metabolism; D009369:Neoplasms / Q000188:drug therapy* / Q000235:genetics; D057285:Precision Medicine; D034741:RNA, Small Interfering / Q000378:metabolism; D014481:United States
D000970:Antineoplastic Agents; D009363:Neoplasm Proteins; D034741:RNA, Small Interfering